Experts Consider Osteoporosis to Be a Silent Epidemic Which Is Neglected and Under Addressed, According to New Survey Released Today - Seite 3

About UCB

UCB, Brussels, Belgium (www.ucb.com) is a global biopharmaceutical company focused on the discovery and development of innovative medicines and solutions to transform the lives of people living with severe diseases of the immune system or of the central nervous system. With 7 500 people in approximately 40 countries, the company generated revenue of € 4.6 billion in 2018. UCB is listed on Euronext Brussels (symbol: UCB). Follow us on Twitter: @UCB_news

References

1. Reginster JY, Burlet N. Osteoporosis: A still increasing prevalence. Bone. 2006 Feb;38 (2 Suppl 1):S4-9
2. Johnell O and Kanis JA (2006). Osteoporos Int 17:1726
3. SERMO. Osteoporosis study for UCB 2019.
4. Bentler SE, et al. Am J Epidemiol. 2009;170:1290-1299.
5. Cosman F, et al. Osteoporos Int. 2014;25:2359-2381. 
6. Kanis JA, Delmas P, Burckhardt P, et al. (1997). Osteoporos Int 7:390.
7. Hernlund E, Svedbom A, Ivergard M, Compston J, et. al. 10.1007/s11657-013-0136-1. 2013, 8(1-2):136
8. 8.  van Geel TA, van Helden S, Geusens PP, Winkens B, Dinant GJ. Ann Rheum Dis 2009;68:99–102.
9. Magaziner J, Simonsick EM, Kashner TM, et al. J Gerontol 1990;45:M101.
10. Cooper C, Atkinson EJ, Jacobsen SJ, et al. Am J Epidemiol 1993;137:1001.
11. Leibson CL, Tosteson AN, Gabriel SE, et al. J Am Geriatr Soc 2002;50:1644.
12. Ström O, Borgström F, Kanis JA, et al. Arch Osteoporos. 2011;6:59-155. doi: 10.1007/s11657-011-0060-1.